RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--
TransEnterix, Inc. (NYSE MKT: TRXC) announced today that it plans to
release fourth quarter and fiscal year 2016 financial and operating
results after the market closes on Monday, March 6, 2017. Todd M. Pope,
President and Chief Executive Officer and Joseph P. Slattery, Executive
Vice President and Chief Financial Officer will host a conference call
to discuss these results starting at 4:30 pm Eastern Time the same day.
The call will be concurrently webcast.
To listen to the conference call on your telephone, please dial,
888-724-9516 for domestic callers and 913-312-0978 for international
callers, and reference TransEnterix Call approximately ten minutes prior
to the start time. To access the live audio webcast or archived
recording, use the following link http://ir.transenterix.com/events.cfm.
The replay will be available on the Company's website.
TransEnterix is a medical device company that is pioneering the use of
robotics to improve minimally invasive surgery by addressing the
clinical and economic challenges associated with current laparoscopic
and robotic options. The company is focused on the commercialization of
the Senhance™ Surgical Robotic System, a multi-port robotic system that
brings the advantages of robotic surgery to patients while enabling
surgeons with innovative technology such as haptic feedback and eye
sensing camera control. The company is also developing the SurgiBot™
System, a single-port, robotically enhanced laparoscopic surgical
platform. The Senhance Surgical Robotic System has been granted a CE
Mark but is not currently available for sale in the United States. For
more information, visit the TransEnterix website at www.transenterix.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170221005263/en/
For TransEnterix, Inc.
(For EU) Conrad Harrington, +44 (0)20 3178 8914
US) Hannah Dunning, +1 415-618-8750
Source: TransEnterix, Inc.
News Provided by Acquire Media